Perrot V - Search Results

1

Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice.

Lambert-Niclot S, Masquelier B, Cohen Codar I, Soulie C, Delaugerre C, Morand-Joubert L, Charpentier C, Ferre V, Plantier JC, Montes B, Carret S, Perrot V, Peytavin G, Costagliola D, Calvez V, Marcelin AG; EOLE Study Group. Lambert-Niclot S, et al. Among authors: perrot v. J Antimicrob Chemother. 2012 Oct;67(10):2487-93. doi: 10.1093/jac/dks226. Epub 2012 Jun 25. J Antimicrob Chemother. 2012. PMID: 22733652

2

Effectiveness and safety of rhIGF1 therapy in patients with or without Laron syndrome.

Bang P, Woelfle J, Perrot V, Sert C, Polak M. Bang P, et al. Among authors: perrot v. Eur J Endocrinol. 2021 Feb;184(2):267-276. doi: 10.1530/EJE-20-0325. Eur J Endocrinol. 2021. PMID: 33434161 Free PMC article.

3

Real-world evidence of cabozantinib in patients with metastatic renal cell carcinoma: Results from the CABOREAL Early Access Program.

Albiges L, Fléchon A, Chevreau C, Topart D, Gravis G, Oudard S, Tourani JM, Geoffrois L, Meriaux E, Thiery-Vuillemin A, Barthélémy P, Ladoire S, Laguerre B, Perrot V, Billard A, Escudier B, Gross-Goupil M. Albiges L, et al. Among authors: perrot v. Eur J Cancer. 2021 Jan;142:102-111. doi: 10.1016/j.ejca.2020.09.030. Epub 2020 Nov 27. Eur J Cancer. 2021. PMID: 33253997 Free article.

4

Effectiveness and Overall Safety of NutropinAq^® for Growth Hormone Deficiency and Other Paediatric Growth Hormone Disorders: Completion of the International Cooperative Growth Study, NutropinAq^® European Registry (iNCGS).

Coutant R, Bosch Muñoz J, Dumitrescu CP, Schnabel D, Sert C, Perrot V, Dattani M. Coutant R, et al. Among authors: perrot v. Front Endocrinol (Lausanne). 2021 May 25;12:676083. doi: 10.3389/fendo.2021.676083. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34113318 Free PMC article.

5

Pubertal Timing and Growth Dynamics in Children With Severe Primary IGF-1 Deficiency: Results From the European Increlex^® Growth Forum Database Registry.

Bang P, Polak M, Perrot V, Sert C, Shaikh H, Woelfle J. Bang P, et al. Among authors: perrot v. Front Endocrinol (Lausanne). 2022 Feb 18;13:812568. doi: 10.3389/fendo.2022.812568. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35250870 Free PMC article.

6

A European, multicentre, observational, post-authorisation safety study of oral sulphate solution: compliance and safety.

Regula J, Spaander MCW, Suchanek S, Kornowski A, Perrot V, Fischbach W; DUS investigators. Regula J, et al. Among authors: perrot v. Endosc Int Open. 2020 Mar;8(3):E247-E256. doi: 10.1055/a-1090-7289. Epub 2020 Feb 21. Endosc Int Open. 2020. PMID: 32140554 Free PMC article.

7

The efficacy and safety of triptorelin-therapy following conservative surgery for deep infiltrating endometriosis: A multicenter, prospective, non-interventional study in China.

Zhu L, Guan Z, Huang Y, Hua K, Ma L, Zhang J, Yang D, Perrot V, Li H, Zhang X. Zhu L, et al. Among authors: perrot v. Medicine (Baltimore). 2022 Feb 4;101(5):e28766. doi: 10.1097/MD.0000000000028766. Medicine (Baltimore). 2022. PMID: 35119037 Free PMC article.

8

Effectiveness and Safety Profile of Ginkgo biloba Standardized Extract (EGb761®) in Patients with Amnestic Mild Cognitive Impairment.

Băjenaru O, Prada G, Antochi F, Jianu C, Tudose C, Cuciureanu A, Docu AA, Perrot V, Avram M, Tiu C. Băjenaru O, et al. Among authors: perrot v. CNS Neurol Disord Drug Targets. 2021;20(4):378-384. doi: 10.2174/1871527320666210208125524. CNS Neurol Disord Drug Targets. 2021. PMID: 33557741 Clinical Trial.

9

Criteria for indication and treatment modification in a cohort of patients with prostate cancer treated with hormone therapy.

Lebret T, Ruffion A, Latorzeff I, Zerbib M, Moreau JL, Rossi D, Pello-Leprince-Ringuet N, Perrot V, Hennequin C. Lebret T, et al. Among authors: perrot v. Ther Adv Urol. 2018 Oct 24;10(12):365-376. doi: 10.1177/1756287218808496. eCollection 2018 Dec. Ther Adv Urol. 2018. PMID: 30574196 Free PMC article.

10

EQUINOXE study: Impact of relational cohesion and sexuality on the quality of life of patients treated with gonadotropin-releasing hormone agonist for prostate cancer.

Droupy S, Colson MH, Pello-Leprince-Ringuet N, Perrot V, Descazeaud A. Droupy S, et al. Among authors: perrot v. BJUI Compass. 2021 Oct 19;3(1):45-54. doi: 10.1002/bco2.92. eCollection 2022 Jan. BJUI Compass. 2021. PMID: 35475155 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters